HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aldosterone induces vascular insulin resistance by increasing insulin-like growth factor-1 receptor and hybrid receptor.

AbstractOBJECTIVE:
We previously showed that aldosterone induces insulin resistance in rat vascular smooth muscle cells (VSMCs). Because insulin-like growth factor-1 receptor (IGF1R) affects insulin signaling, we hypothesized that aldosterone induces vascular insulin resistance and remodeling via upregulation of IGF1R and its hybrid insulin/insulin-like growth factor-1 receptor.
METHODS AND RESULTS:
Hybrid receptor expression was measured by immunoprecipitation. Hypertrophy of VSMCs was evaluated by (3)H-labeled leucine incorporation. Aldosterone (10 nmol/L) significantly increased protein and mRNA expression of IGF1R and hybrid receptor in VSMCs but did not affect insulin receptor expression. Mineralocorticoid receptor blockade with eplerenone inhibited aldosterone-induced increases in IGF1R and hybrid receptor. Aldosterone augmented insulin (100 nmol/L)-induced extracellular signal-regulated kinase 1/2 phosphorylation. Insulin-induced leucine incorporation and α-smooth muscle actin expression were also augmented by aldosterone in VSMCs. These aldosterone-induced changes were significantly attenuated by eplerenone or picropodophyllin, an IGF1R inhibitor. Chronic infusion of aldosterone (0.75 μg/hour) increased blood pressure and aggravated glucose metabolism in rats. Expression of hybrid receptor, azan-positive area, and oxidative stress in aorta was increased in aldosterone-infused rats. Spironolactone and tempol prevented these aldosterone-induced changes.
CONCLUSIONS:
Aldosterone induces vascular remodeling through IGF1R- and hybrid receptor-dependent vascular insulin resistance. Mineralocorticoid receptor blockade may attenuate angiopathy in hypertensive patients with hyperinsulinemia.
AuthorsShamshad J Sherajee, Yoshiko Fujita, Kazi Rafiq, Daisuke Nakano, Hirohito Mori, Tsutomu Masaki, Taiga Hara, Masakazu Kohno, Akira Nishiyama, Hirofumi Hitomi
JournalArteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol) Vol. 32 Issue 2 Pg. 257-63 (Feb 2012) ISSN: 1524-4636 [Electronic] United States
PMID22173225 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Insulin
  • Spironolactone
  • Aldosterone
  • Eplerenone
  • Receptor, IGF Type 1
  • Receptor, Insulin
  • Glucose
Topics
  • Aldosterone (pharmacology)
  • Animals
  • Aorta, Thoracic (drug effects, metabolism, pathology)
  • Blood Pressure (drug effects)
  • Cells, Cultured
  • Chimera (genetics)
  • Eplerenone
  • Glucose (metabolism)
  • Hypertrophy
  • Insulin (pharmacology)
  • Insulin Resistance
  • Male
  • Models, Animal
  • Muscle, Smooth, Vascular (drug effects, metabolism, pathology)
  • Oxidative Stress (drug effects)
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, IGF Type 1 (genetics, metabolism)
  • Receptor, Insulin (genetics, metabolism)
  • Spironolactone (analogs & derivatives, pharmacology)
  • Up-Regulation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: